Figure 1. FACS analysis of cynomolgus BDCA2 expression in CHO-K1/cyno BDCA2/cyno FcER1G cells. The CHO-K1/cyno BDCA2/cyno FcER1G cells (blue) and the negative control CHO-K1 cells (red) were probed using PE conjugated Anti-BDCA2 (Cat. No. 130-090-511, Miltenyi).

CHO-K1/cyno BDCA2 and FcER1G Stable Cell Line

Recombinant CHO-K1 cells stably overexpress cynomolgus C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis.

产品编号	M00594
规格	2 vials 大单询价
数量
价格	询价


联系我们

产品简介

Product Description	Recombinant CHO-K1 cells stably overexpress cynomolgus C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis.
Culture Properties	Adherent
Stability	Stable through more than 16 passages without significant changes in assay performance or expression profile.
Size	Two vials of frozen cells (>1×10⁶ per vial in 1 mL)
Storage	Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.

培养条件

Culture Medium	Ham’s F-12K (Kaighn’s), 10% FBS, 4 μg/ml Puromycin (Cat. No. A11138-03, Life Techonologies)
Complete Growth Medium	Ham’s F-12K (Kaighn’s) (Cat. No. 21127-022, Life Techonologies), 10% FBS (Cat. No. 10099-141, Life Techonologies)
Freeze Medium-DATA	95% complete growth medium, 5% (V/V) DMSO (Cat. No. D2650, Sigma)

图例

Figure 1. FACS analysis of cynomolgus BDCA2 expression in CHO-K1/cyno BDCA2/cyno FcER1G cells. The CHO-K1/cyno BDCA2/cyno FcER1G cells (blue) and the negative control CHO-K1 cells (red) were probed using PE conjugated Anti-BDCA2 (Cat. No. 130-090-511, Miltenyi).

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.

CHO-K1/cyno BDCA2 and FcER1G Stable Cell Line

资源中心

技术支持

关于我们